Chiron Real Estate Inc Preferred Series B (XRN_PB)

Chiron Real Estate Inc. Preferred Series B (NYSE: XRN.PRB) is a preferred stock listing associated with Chiron Real Estate Inc., a Maryland-based real estate investment trust incorporated in 2011. The REIT focuses on net-lease medical properties, acquiring healthcare facilities and leasing them to physician groups as well as regional and national healthcare systems. As a preferred security, this listing represents an equity-linked instrument tied to the issuer rather than the company’s common stock.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-XRN.PRB
$25.40
0.6% Upside
Fair
Not available
Not available
Good
7.9%
8.5x
0.9x
2.6x
406.8 M
1.256 B
49.3%
92.4%
0.2
89.3%
162.4%
Valuation • Fair Value

Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) Fair Value by Valuation Model

Review the available estimates for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB), including Ben Graham Formula Value, DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$25.40

Estimated upside of 0.6% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

Ben Graham Formula Value

$27

Classic Ben Graham valuation formula reference.

DDM Fair Value

$18.98

Dividend discount model valuation reference.

Comps Fair Value

$27

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 5 available valuation references for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

156.4 M

Current operating scale indicator.

Revenue Forecast

155 M

Forward revenue estimate.

EBITDA

86.375 M

Current operating profitability reference.

EBITDA Forecast

97.219 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-3.16

No elevated caution signal from this screen.

Altman Z-Score

0.2

Lower score that deserves closer risk review.

FCF / Net Income

162.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

7.9%

Current income yield reference.

Payout Ratio

89.3%

Dividend payout reference.

How to read events and dividends

Review the currently available dividend data for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB). No upcoming company event date is included in the latest data.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Buy

The 1-hour technical read for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Sell

The weekly technical read for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) Stock FAQ

Data-supported answers about Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$25.40
Estimated upside 0.6%
Valuation Rating
Near Fair Value
Price is close to fair value
Financial Health
Good
Current financial-health read

The current fair value estimate for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is $25.40. This implies an estimated upside of 0.6% versus the current market price.

Based on the current fair value estimate, the stock is trading close to its estimated fair value.

The current financial health read for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Based on the current data, dividend yield is 7.9%.

The current P/E ratio listed for Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is 8.5x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Chiron Real Estate Inc Preferred Series B is 406.8 M.

The current enterprise value listed for Chiron Real Estate Inc Preferred Series B is 1.256 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Chiron Real Estate Inc Preferred Series B is NYSE-XRN.PRB, and the stock is listed on NYSE.

Chiron Real Estate Inc Preferred Series B (NYSE-XRN.PRB) is listed on NYSE.

The current debt-to-total-capital ratio listed for Chiron Real Estate Inc Preferred Series B is 49.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Chiron Real Estate Inc Preferred Series B is 92.4%. Free float helps investors understand how much of the share base is available for public trading.